5′ and 3′ untranslated region polymorphisms of thymidylate synthase gene in Korean population

Korean Journal of Genetics

Volumn 27, Issue 2, 2005, Pages 161-168

  Dong, Jin Yim ^a   Jin, Hee Han ^a   Seung, Il Ji ^a   Seong, Gyu Hwang ^a   Oh, Doyeun ^a   Nam, Keun Kim ^a  

^a CHA University   (South Korea)

Author keywords

Polymorphism; Thymidylate synthase; Untranslated region

Indexed keywords

EID: 22244480642     PISSN: 02545934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Adleff V, Hitre E, Koves I, Orosz Z, Hajnal A and Kralovanszky J (2004) Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients. Int. J. Cancer 108(6): 852-856.
2. Brown KS, Kluijtmans LA, Young IS, McNulty H, Mitchell LE, Yarnell JW, Woodside JV, Boreham CA, McMaster D, Murray L, Strain JJ and Whitehead AS (2004) The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects. Hum. Genet. 114(2): 182-185.
3. Choi SW and Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J. Nutr. 132(8): 2413-2418.
4. Etienne MC, Ilc K, Formento JL, Laurent-Puig P, Formento P, Cheradame S, Fischel JL and Milano G (2004) Thymidylate synthase and methylene- tetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. Br. J. Cancer 90(2): 526-534.
5. Goto Y, Yue L, Yokoi A, Nishimura R, Uehara T, Koizumi S and Saikawa Y (2001) A novel single-nucleotide polymorphism in the 3′-untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin. Cancer Res. 7(7): 1952-1956.
6. Graziano F, Kawakami K, Watanabe G, Ruzzo A, Humar B, Santini D, Catalano V, Ficarelli R, Merriman T, Panunzi S, Testa E, Cascinu S, Bearzi I, Tonini G and Magnani M (2004) Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. Int. J. Cancer 112(6): 1010-1014.
7. Hone N and Takeishi K (1997) Identification of functional elements in the promoter region of the human gene for thymidylate synthase and nuclear factors that regulate the expression of the gene. J. Biol. Chem. 272(29): 18375-18381.
8. Huang CM, Chen CL, Tsai JJ, Tsai CH and Tsai FJ (2004) Association between urokinase gene 3′-UTR T/C polymorphism and Chinese patients with rheumatoid arthritis in Taiwan. Clin. Exp. Rheumatol. 22(2): 219-222.
9. Kang BY, Kim KT, Shin JH, Lee CC, Lee KO and Bae JS (2002) Haplotype distribution of the apolipoprotein B gene in Korean essential hypertensives. Korean J. Genetics 24(1): 59-67.
10. Kawakami K and Watanabe G (2003) Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Res. 63(18): 6004-6007.
11. Kim JK, Cho SH, Kim NK, Kim OJ, Cho YK, Chung HM, Hwang SG and Oh D (2003) Genetic polymorphism of thymidylate synthase enhancer region (TSER) in Korean. Korean J. Genetics 25(4): 287-291.
12. Kuersten S and Goodwin EB (2003) The power of the 3′ UTR: translational control and development. Nat. Rev. Genet. 4(8): 626-637.
13. Kumagai K, Hiyama K, Oyama T, Maeda H and Kohno N (2003) Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int. J. Mol. Med. 11(5): 593-600.
14. Lauten M, Asgedom G, Weite K, Schrappe M and Stanulla M (2003) Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia. Haematologica 88(3): 353-354.
15. Lee Y and Johnson LF (2000) Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features. Exp. Cell Res. 258(1): 53-64.
16. Lin X, Parsels LA, Voeller DM, Allegra CJ, Maley GF, Maley F and Chu E (2000) Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA. Nucleic Acids Res. 28(6): 1381-1389.
17. Luo HR, Lu XM, Yao YG, Hone N, Takeishi K, Jorde LB and Zhang YP (2002) Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles. Biochem. Genet. 40(1-2): 41-51.
18. Maeng JHn and Yoon JB (1998) The human PTFgamma/SNAP43 gene: structure, chromosomal location, and identification of a VNTR in 5′-UTR. J. Biochem. 124(1): 23-27.
19. Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ and Ladner RD (2003) A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res. 63(11): 2898-2904.
20. Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lenz HJ and Ladner RD (2004) A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14(5): 319-327.
21. Marsh S, McKay JA, Cassidy J and McLeod HL (2001) Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer. Int. J. Oncol. 19(2): 383-386.
22. Mill J, Asherson P, Browes C, D'Souza U and Craig I (2002) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am. J. Med. Genet. 114(8): 975-979.
23. Moor CH, Meijer H and Lissenden S (2005) Mechanisms of translational control by the 3′UTR in development and differentiation. Semin. Cell Dev. Biol. 16(1): 49-58.
24. Nilsson TK and Borjel AK (2004) Novel insertion and deletion mutations in the 5′-UTR of the folate receptor-alpha gene: an additional contributor to hyperhomocysteinemia? Clin. Biochem. 37(3): 224-229.
25. Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, Warren R, Tsao-Wei D, Groshen S and Lenz HJ (2001) Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 1(1): 65-70.
26. Trinh BN, Ong CN, Coetzee GA, Yu MC and Laird PW (2002) Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum. Genet. 111(3): 299-302.
27. Tsuji T, Hidaka S, Sawai T, Nakagoe T, Yano H, Haseba M, Komatsu H, Shindou H, Fukuoka H, Yoshinaga M, Shibasaki S, Nanashima A, Yamaguchi H, Yasutake T and Tagawa Y (2003) Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer. Clin. Cancer Res. 9(10 Pt1): 3700-3704.
28. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM and Potter JD (2000) Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol. Biomarkers Prev. 9(12): 1381-1385.
29. Zhang J, Cui Y, Kuang G, Li Y, Wang N, Wang R, Guo W, Wen D, Wei L, Yu F and Wang S (2004) Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis 25(12): 2479-2485.